Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Equipment and Processing Report

Parenteral Packaging Equipment On Display at INTERPHEX

March 08, 2017

Parenteral packaging will be well-represented at INTERPHEX, especially technologies associated with fill/finish of ready-to-use vials, cartridges, and syringes.

Understanding Containment

March 02, 2017

The new ISPE Containment Manual is a summary of the process involved in the manufacture of highly active or highly hazardous pharmaceutical substances.

Oral Delivery of Biologic APIs: The Challenge Continues

March 02, 2017

Effective solutions for overcoming the high molecular weight, hydrophilicity, and instability of large biomolecules have yet to be identified.

Operational Excellence at Baxter BioPharma Solutions

March 02, 2017

Pharmaceutical Technology spoke with Frank Generotzky, plant manager for Baxter BioPharma Solutions’ Halle, Germany facility, about operational excellence at the site.

UKSCB Releases Stem Cell Lines for Development

March 01, 2017

The UK Stem Cell Bank released validated stem-cell lines for researchers developing novel cell-based therapies for clinical trials.

Sanofi and Lonza Partner on mAb Cell Culture Facility in Switzerland

February 27, 2017

Sanofi and Lonza formed a joint venture to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.

Orphan Drug Natpar Receives EMA Recommendation

February 24, 2017

The agency’s CHMP recommended conditional marketing authorization for the hormone replacement therapy for the treatment of chronic hypoparathyroidism.

Can Bigger be Better?

February 23, 2017

The industry is becoming more consolidated, but there needs to be some strategy behind the mergers and acquisitions.

Abzena Signs Antibody Manufacturing Development Agreement with UCL

February 21, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Under the agreement, Abzena will manufacture magacizumab, an antibody created using the ‘Abzena inside’ Composite Human Antibody technology.

Past, Present, and Future Trends Affecting the Bio/Pharmaceutical Industry

February 17, 2017

The trends in the year 2017 will present the industry with new challenges, and companies will be able to meet them successfully if they focus on the issues at hand.